Human embryonic stem cell therapy in the post-Geron era

被引:4
作者
Brindley, David [1 ,2 ,3 ]
Mason, Chris [1 ]
机构
[1] UCL, Adv Ctr Biochem Engn, London, England
[2] Harvard Stem Cell Inst, Cambridge, MA USA
[3] Harvard Univ, Sch Business, Boston, MA 02163 USA
关键词
D O I
10.2217/rme.11.115
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
引用
收藏
页码:17 / 18
页数:2
相关论文
共 2 条
[1]
The Impact of Market Volatility on the Cell Therapy Industry [J].
Brindley, David A. ;
Reeve, Brock C. ;
Sahlman, William A. ;
Bonfiglio, Greg A. ;
Davie, Natasha L. ;
Culme-Seymour, Emily J. ;
Mason, Chris .
CELL STEM CELL, 2011, 9 (05) :397-401
[2]
Embryonic stem cell lines derived from human blastocysts [J].
Thomson, JA ;
Itskovitz-Eldor, J ;
Shapiro, SS ;
Waknitz, MA ;
Swiergiel, JJ ;
Marshall, VS ;
Jones, JM .
SCIENCE, 1998, 282 (5391) :1145-1147